$ALAB

Dyckerhoff Stefan A sold $2.5M of ALAB (indirect holdings)

Dyckerhoff Stefan A sold 8,994 indirectly-held shares of Astera Labs, Inc. (ALAB) at an average of $274.96 ($273.64–$276.75, $2.47M total) across 8 trades on 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dyckerhoff Stefan A
Published Sep 3, 2026, 11:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 11:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALAB
Neutral
medium confidence
Mentioned
$ALAB
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALABNeutralLow
01

Why it matters

The transaction provides fresh data on insider holdings but is unlikely to move the stock significantly.

02

Market read

Insider sale of modest size; traders may note but not act aggressively.

03

What to watch

The director still holds over 3,000 shares, indicating continued belief in the company.

Relevance 5/10Novelty 5/10Timing: post‑market 2026‑09‑02

Background

Form 4 filings disclose insider transactions; a director's sale via a pre‑arranged plan is a standard compliance disclosure.

Company-level read

Ticker impact

$ALABNeutralMedium confidence
Context

Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs for $2.47M via a 10b5‑1 plan, reducing his holding to 3,309 shares.

Expected impact

Potential short‑term downward pressure, likely limited to a few basis points.

Evidence & confidence

A $2.5M sale by a director is a routine 10b5‑1 execution; markets typically view such trades as low‑impact unless the insider is a major shareholder.

Market effects

Minor signal for the semiconductor equipment sector; no broader industry impact.

U.S. market only; no regional ripple effects.

Limited to investors tracking Astera Labs.

Counterpoint

The sale could be purely procedural under a 10b5‑1 plan, not reflecting insider confidence.

Key entities

  • Astera Labs, Inc.

    U.S. listed semiconductor firm (ticker ALAB).

  • Stefan A. Dyckerhoff

    Director of Astera Labs executing a 10b5‑1 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALABMedAI 8/10

What Astera Labs (ALAB) Said on Its Q3 Earnings Call

Astera Labs (ALAB) forecasted Q4 revenue of $730M-$750M, up 27% sequentially, with non-GAAP EPS of $1.62-$1.66. The company expects growth from Scorpio, Aries, and Taurus products, and plans new optical and AI solutions. Operating expenses are rising to support customer programs and R&D, with long-term targets of 30% of revenue.

$AMDMed

AMD, Super Micro Computer, Arista Networks, Astera Labs and Nvidia: Why These 5 Stocks Are on Investors' Radars Today

AMD, Super Micro Computer, Arista Networks, Astera Labs, and Nvidia were among stocks gaining attention. AMD reported Q3 revenue of $13.38B, up 45% YoY, and forecasted Q4 revenue of ~$17B. Super Micro Computer saw Q1 2027 revenue of $19.95B, up 297% YoY, and raised full-year outlook. Arista Networks reported Q3 revenue of $3.66B and forecasted Q4 revenue of $3.9B-$4B. Astera Labs reported Q3 revenue of $584.90M, up 154% YoY, and forecasted Q4 revenue of $730M-$750M.

$ALABHighAI 8/10

Astera Labs Reports Third Quarter 2026 Financial Results

Astera Labs, Inc. (ALAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IR CONTACT: Leslie Green leslie.green@asteralabs.com Astera Labs Reports Third Quarter 2026 Financial Results • Record quarterly revenue of $584.9 million, up 49% QoQ and up 154% year-over-year • Scorpio™ fabric switches became the company's largest product family, l